Astera Labs, Inc. $ALAB Stock Holdings Trimmed by Sterling Capital Management LLC

Sterling Capital Management LLC lowered its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 48.6% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 2,944 shares of the company’s stock after selling 2,779 shares during the quarter. Sterling Capital Management LLC’s holdings in Astera Labs were worth $1,048,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the business. Amazon Com Inc. purchased a new stake in shares of Astera Labs in the second quarter valued at approximately $134,172,000. Edgestream Partners L.P. purchased a new stake in shares of Astera Labs during the 1st quarter worth $1,891,000. Lido Advisors LLC boosted its position in shares of Astera Labs by 123.4% during the 1st quarter. Lido Advisors LLC now owns 27,477 shares of the company’s stock worth $3,012,000 after purchasing an additional 15,180 shares in the last quarter. Strs Ohio grew its stake in shares of Astera Labs by 996.3% during the 1st quarter. Strs Ohio now owns 33,086 shares of the company’s stock worth $3,626,000 after purchasing an additional 30,068 shares during the period. Finally, Silvant Capital Management LLC acquired a new position in shares of Astera Labs during the 2nd quarter worth $11,277,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Insider Activity

In related news, Director Stefan Dyckerhoff sold 8,994 shares of the firm’s stock in a transaction that occurred on Wednesday, October 7th. The shares were sold at an average price of $376.06, for a total transaction of $3,382,283.64. Following the sale, the director owned 2,648 shares in the company, valued at approximately $995,806.88. This trade represents a 77.25% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 90,630 shares of the business’s stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the transaction, the chief operating officer owned 1,119,038 shares of the company’s stock, valued at $380,864,583.30. This trade represents a 7.49% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 408,558 shares of company stock valued at $127,306,034 in the last 90 days. Insiders own 10.40% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the stock. Weiss Ratings downgraded shares of Astera Labs from a “buy (b-)” rating to a “hold (c)” rating in a report on Friday. UBS Group reissued a “neutral” rating and set a $425.00 price objective on shares of Astera Labs in a report on Wednesday, August 5th. Susquehanna upped their target price on shares of Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a research report on Friday, July 31st. TD Cowen dropped their target price on shares of Astera Labs from $375.00 to $300.00 and set a “hold” rating for the company in a report on Monday, October 19th. Finally, Needham & Company LLC lifted their price target on shares of Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a research report on Wednesday, August 5th. Eleven research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $340.79.

Astera Labs Stock Up 0.9%

Shares of NASDAQ:ALAB opened at $259.51 on Tuesday. The stock’s fifty day simple moving average is $310.76 and its 200-day simple moving average is $252.11. Astera Labs, Inc. has a 52-week low of $97.89 and a 52-week high of $499.48. The company has a market capitalization of $45.02 billion, a P/E ratio of 128.47 and a beta of 3.68.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. The company had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm’s quarterly revenue was up 104.5% on a year-over-year basis. During the same period in the prior year, the firm earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, sell-side analysts anticipate that Astera Labs, Inc. will post 2.71 earnings per share for the current year.

Astera Labs Profile

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.